Alvotech acquires Xbrane’s R&D operations and the biosimilar candidate XB003. Xbrane retains some pre-clinical development programs, that it intends to commercialize, and will continue operating as a ...

Chairman and CEO of Alvotech. “Furthermore, we will establish a strong presence for Alvotech in the Swedish life science sector, which rivals the U.S. in this field. It will allow Alvotech to ...

Chairman and CEO of Alvotech. “Furthermore, we will establish a strong presence for Alvotech in the Swedish life science sector, which rivals the U.S. in this field. It will allow Alvotech to attract ...

CEO of AMiLi; and dr Michael Gorriz, former global CIO of Standard Chartered Bank — all of whom have played pivotal roles in the company’s growth. To date, the platform has onboarded leading suppliers ...

DKSH Business Unit Technology has initiated “UniTEC Connect,” a platform to provide students and researchers with insights ...

March 17 (Reuters) - Swiss private bank Julius Baer (BAER.S), opens new tab delivered a total pay package to its ad interim chief executive officer Nic Dreckmann of 5.8 million Swiss francs ($6.56 ...

Alvotech’s CEO highlighted the move as a significant step towards strengthening the company’s position in the biosimilars market and enhancing patient access to biologics globally. Acquisition ...

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as "Dr. Reddy's”) and Alvotech (NASDAQ: ALVO), a global biotech ...

During his 20-year career in emerging markets, he held country and regional positions at Nycomed, Invida, DKSH, Novartis and Sandoz, working in the proprietary and branded generics pharmaceuticals ...